Table 2 Quantitative MRI results at baseline (B) and follow-up (F)
Subject | Synovial volume (cm3) | Maximum uptake rate (%/s) | Signal enhancement (%) | Radiologist reports synovial enhancement beyond normal limits (Y/N) | Clinician assessed disease activity in injected knee (Y /N) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Â | B | F | B | F | B | F | B | F | B | F |
1 | 25.7 | 0.0 | 1.5 | 0.0 | 116 | 0 | Y | N | Y | Y (rpt IAGI) |
2 | 0.6 | – | 0.5 | – | 35 | – | N | – | Y | – |
3 | 1.2 | 0.0 | 0.4 | 0.0 | 57 | 0 | N | N | Y | N |
4 | 51.2 | 0.1 | 1.8 | 0.4 | 148 | 109 | Y | N | Y | Y (rpt IAGI) |
5 | 72.2 | 0.7 | 2.8 | 0.5 | 190 | 90 | Y | N | Y | N |
6 | 0.1 | 0.0 | 0.0 | 0.0 | 10 | 6 | N | N | Y | N |
7 | 92.2 | 0.0 | 6.7 | 0.0 | 225 | 0 | Y | N | Y | N |
8 | 101.6 | 1.9 | 4.6 | 1.9 | 157 | 126 | Y | N | Y | Y (rpt IAGI) |
9 | 87.0 | 0.0 | 7.1 | 0.0 | 228 | 0 | Y | N | Y | N |
10 | 1.2 | 0.0 | 0.6 | 0.0 | 95 | 0 | N | N | Y | N |
11 | 1.1 | 0.2 | 1.5 | 0.8 | 145 | 103 | N | N | Y | N |
Median | 38.5 | 0.0†| 1.7 | 0.0$ | 147 | 3†| – | – |  |  |
IQR | 82.1 | 0.2 | 3.3 | 0.5 | 82 | 100 | – | – |  |  |